Your address will show here +12 34 56 78
  • Text Hover
About Optiscan

Optiscan (ASX:OIL) is a global leader in the development and application of endomicroscopic imaging technologies for medical, translational and pre-clinical markets. Our technology, used by leading research institutions and hospitals in North America, Europe, Asia and Australia enables real-time, in vivo imaging at the cellular level in human and animal tissue. In collaboration with Carl Zeiss Meditec, we are enabling the application of confocal endomicroscopy during brain surgery and together with Pentax Medical released the first-ever human confocal endomicroscopy for gastroenterology. Our recently launched FIVE2 ViewnVivo system builds upon our successful FIVE1 platform with enhanced 3D imaging features enabling virtual biopsies in living, breathing, moving tissue. New applications in the identification of dysplastic and diseased tissue, tumour margins, molecular disease markers, women’s health, veterinary and research applications are being developed in association with world-leading institutions. We strive to give health care providers and researchers the highest quality in-vivo microscopic imaging tools available to enable the early detection and management of disease, in order to improve patient outcomes and reduce the high cost of curative medicine.

The Optiscan Vision

To become a global leader in microscopic imaging techniques for the medical market.

The Optiscan Values

The highest level of integrity, commercially orientated innovation and technology leadership, understanding applications of our technology in medicine, personal skill development and growth, and design rigour through showing initiative, and being persistent and timely.

The Optiscan Mission

To create Shareholder wealth through the profitable delivery of microscopic imaging and related technologies into the global market.

The Optiscan Board and Management Team

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porta, mi ut facilisis ullamcorper, magna risus vehicula augue, eget faucibus magna massa at justo. Sed quis augue ut eros tincidunt hendrerit eu eget nisl. Duis malesuada vehicula massa... Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porta, mi ut facilisis ullamcorper, magna risus vehicula augue, eget faucibus magna massa at justo. Sed quis augue ut eros tincidunt hendrerit eu eget nisl.

Darren Lurie

CHAIRMAN AND NON-EXECUTIVE DIRECTOR




Darren Lurie is an experienced leader of boards and management teams as Chair, CEO and CFO. He has experience working across a range of industries operating both domestically and internationally. Prior to joining Optiscan, Darren was the Group CFO and Head of Corporate Development for EduCo International Group, an investee company of Baring Private Equity Asia and a leading provider of education and related services with campuses in the USA, Australia, Canada and Ireland, across the Higher Education, Career and English sectors. In this role, he managed the treasury and finance activities of the group and was responsible for all corporate development opportunities including mergers, acquisitions, partnerships and greenfields opportunities. As part of this role, he led Educo’s team in the successful undertaking and implementation of a European acquisition, Canadian acquisition and multiple University partnership arrangements. Darren is a former chair and non-executive director of ASX listed Farm Pride Foods Ltd (ASX:FRM), one of Australia’s leading agribusinesses.He has fifteen years’ experience as a corporate advisor leading finance, strategy and merger and acquisition assignments across a range of industries where he advised and executed multiple transactions with an enterprise value in excess of A$500m. Prior to this he was a mergers and acquisitions solicitor for leading law firms. Darren has honours degrees in both Commerce (Accounting and Finance) and Law from Monash University.

Dr Philip Currie MBBS (Hons), FRACP, MBA

 NON-EXECUTIVE DIRECTOR


Philip Currie is a cardiologist with more than 30 years in cardiology both in the United States and in Australia with extensive experience in medical research, clinical cardiology and business. He has a medical degree, MBBS (Hons) from Monash University and an MBA from the University of Michigan. He completed his medical residency and cardiology fellowship at the Alfred Hospital in Melbourne before moving to the USA in 1983. At the Mayo Clinic, he completed a cardiology fellowship and then was a Senior Associate Cardiologist. He then was a staff cardiologist for 3 years at the Cleveland Clinic and then to Michigan as the Director of Echocardiography at the Michigan Heart and Vascular Institute for 8 years. During this time he was involved in the research/pioneering/validation of many of the major advances in echocardiography (Doppler echo, intraoperative echocardiography and transoesophageal echocardiography) including working closely as a luminary with the major international ultrasound manufacturers. In 1997, after working in the USA for 14 years, Philip returned to Australia and over the last 20 years he has successfully established a private cardiology practice which has subsequently evolved to become an integrated multispecialty medical organisation with 12 sites in Perth and Melbourne. Dr Philip Currie brings to the board a wide range of skills and broad experience including medical knowledge, medical research background, experience as the luminary interacting with international ultrasound companies, and extensive business skills based on previous MBA and a 20 year experience as the founder, owner and CEO of a large integrated medical organisation.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porta, mi ut facilisis ullamcorper, magna risus vehicula augue, eget faucibus magna massa at justo. Sed quis augue ut eros tincidunt hendrerit eu eget nisl. Duis malesuada vehicula massa... Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porta, mi ut facilisis ullamcorper, magna risus vehicula augue, eget faucibus magna massa at justo. Sed quis augue ut eros tincidunt hendrerit eu eget nisl.

Graeme Mutton

 NON-EXECUTIVE DIRECTOR




Graeme is an independent non-executive director and joined the Board on 20th April 2018. After graduating in Accounting in 1968, Graeme managed a public accounting practice for CP Bird and Associates at Bruce Rock in Western Australia for approximately five years. During this time, he purchased City Plating Company, an electroplating business which he successfully managed for 30 years until it was sold in 2000. This background exposed him to many businesses and provided a practical knowledge of all aspects required to successfully operate a small to medium enterprise. Graeme is a long standing shareholder of Optiscan and has a deep understanding of Optiscan`s technology and applications. He has a pragmatic approach that will help ensure with other members of the Board and staff that Optiscan products and technology are marketed and applied to achieve optimal outcomes for all stakeholders.

Peter Delaney

CHIEF TECHNOLOGY OFFICER 


Peter Delaney completed a science degree with honours in Pharmacology at Monash University in 1989. He has played a major role in the refinement of the fibre optic approach to produce a commercial instrument which received an R&D 100 Award in 1991. In 1993, Mr Delaney received the Victorian Young Achiever Award (Science and Technology) for his development of the company strategy and infrastructure. In April 2007, Peter Delaney was awarded a prestigious ATSE Clunes Ross award for excellence in the innovation and commercialisation of scientific endeavours.

Justin Mouchacca

COMPANY SECRETARY 


Justin Mouchacca holds a Bachelor of Business majoring in Accounting. He graduated from RMIT University in 2008, became a Chartered Accountant in 2011 and since July 2013 has been the principal of chartered accounting firm, Leydin Freyer Corp Pty Ltd. The practice provides outsourced company secretarial and accounting services to public and private companies specialising in the Resources, technology, bioscience and biotechnology sectors. Justin has over 10 years’ experience in the accounting profession and has extensive experience in relation to public company responsibilities, including ASX and ASIC compliance, control and implementation of corporate governance, statutory financial reporting, reorganisation of Companies and shareholder relations.

Partners

Discover who is currently helping achieve the Optiscan mission.

Investors

Interested in investing in an Australian company that is making the world a healthier place?

News

See what we have been up to on our mission to make health easier.